It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.
When US President Joe Biden talks about his Cancer Moonshot, he's not literally talking about the moon - he's referencing the legendary innovation push that got Americans to the moon in 196
At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy
The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.
Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo